Prothena Corporation plc (PRTA) Q4 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by and welcome to Prothena's fourth quarter full year 2021 financial results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, again, press star one. We ask that you please limit yourself to one question. Thank you. Jennifer Zabuda, you may begin your conference. Jennifer Zabuda Thank you, Operator. Good afternoon, everyone, and welcome to Prothena's investor conference call to review our business progress, our fourth quarter and full year 2021 financial results, and the press release we issued earlier today, which is available on our website at Prothena.com and is also attached to a Form 8-K filed today with the SEC. On today's call, Dr. Jean Kinney, our President and Chief Executive Officer, will highlight Provena's progress across our portfolio in 2021, as well as our organizational evolution as we continue advancing towards becoming a fully integrated biotechnology company. Following Jean's comments, Tran Nguyen, our Chief Financial Officer and Chief Strategy Officer, will review our financial results and performance for the fourth quarter and full year of 2021 and will provide our 2022 financial guidance before turning it back to Jean for closing remarks. We will then open the call for Q&A and be joined by Dr. Hideki Garan, our Chief Medical Officer, and Dr. Wagner Zago, our Chief Scientific Officer. Before we begin, I would like to remind you that during today's presentation, we will be making forward-looking statements that are subject to cer...